This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fox Chase Cancer Center. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Andreas Lehmann: Innovator in Cancer Research
Introduction
Andreas Lehmann is a notable inventor based in Bear, DE (US). He has made significant contributions to the field of cancer research, particularly through his innovative work on antibodies.
Latest Patents
Lehmann holds 1 patent for his invention titled "Rationally-designed anti-mullerian inhibiting substance type II receptor antibodies." This patent outlines methods for generating hybrid antibodies, which have potential applications in cancer treatment.
Career Highlights
Andreas Lehmann is currently affiliated with the Fox Chase Cancer Center, where he continues to advance research in oncology. His work focuses on developing novel therapeutic strategies to combat cancer.
Collaborations
Lehmann collaborates with esteemed colleagues, including Gregory P. Adams and Heidi H. Simmons, to enhance the impact of his research and foster innovation in the field.
Conclusion
Andreas Lehmann's contributions to cancer research through his patented innovations exemplify the vital role of inventors in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile